CVE-2023-21922

CVE-2023-21922 is a medium-severity vulnerability in Oracle Health Sciences Inform with a CVSS 3.x base score of 6.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-284.

Key facts

Description

Vulnerability in the Oracle Health Sciences InForm product of Oracle Health Sciences Applications (component: Core). Supported versions that are affected are Prior to 6.3.1.3 and Prior to 7.0.0.1. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Health Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Health Sciences InForm accessible data as well as unauthorized access to critical data or complete access to all Oracle Health Sciences InForm accessible data. CVSS 3.1 Base Score 6.8 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:N).

Frequently asked questions

What is CVE-2023-21922?
Vulnerability in the Oracle Health Sciences InForm product of Oracle Health Sciences Applications (component: Core). Supported versions that are affected are Prior to 6.3.1.3 and Prior to 7.0.0.1. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Health Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Health Sciences InForm accessible data as well as unauthorized access to critical data or complete access to all Oracle Health Sciences InForm accessible data. CVSS 3.1 Base Score 6.8 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:N).
How severe is CVE-2023-21922?
CVE-2023-21922 has a CVSS 3.x base score of 6.8, rated medium severity. It is exploitable over network with high attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity high, and availability none.
Is CVE-2023-21922 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (39th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-21922?
CVE-2023-21922 primarily affects Oracle Health Sciences Inform. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-21922?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-21922 published?
CVE-2023-21922 was published on 2023-04-18 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Oracle Health Sciences Inform

All CVEs affecting Oracle Health Sciences Inform →

Other CWE-284 (Improper Access Control) vulnerabilities

Browse all CWE-284 (Improper Access Control) vulnerabilities →